<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T08:25:04Z</responseDate>
  <request identifier="oai:figshare.com:article/34048468" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34048468</identifier>
        <datestamp>2026-10-01T17:33:45Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Health benefits and physiological actions of micronutrients, probiotics/prebiotics, phytochemicals, and their associated deficiency diseases: a systematic review of recent developments and applications</dc:title>
          <dc:creator>Chinaza Godswill Awuchi (17838704)</dc:creator>
          <dc:creator>Ayomide Victor Atoki (20880691)</dc:creator>
          <dc:creator>Chinelo Kate Echeta (25157782)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Micronutrients</dc:subject>
          <dc:subject>probiotics</dc:subject>
          <dc:subject>nutritional deficiencies</dc:subject>
          <dc:subject>gut dysbiosis</dc:subject>
          <dc:subject>immune modulation</dc:subject>
          <dc:subject>synbiotic interventions</dc:subject>
          <dc:subject>precision nutrition</dc:subject>
          <dc:subject>Nutrition and Dietetics</dc:subject>
          <dc:subject>Clinical Nutrition</dc:subject>
          <dc:subject>Nutrition</dc:subject>
          <dc:subject>Food Chemistry</dc:subject>
          <dc:subject>Sports Nutrition</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Food Microbiology</dc:subject>
          <dc:description>&lt;p&gt;Micronutrients, probiotics/prebiotics, and phytochemicals influence physiological function, but benefits vary by baseline nutritional status, intervention, population, and outcome. This systematic review synthesizes evidence from primary research and high-quality reviews (2016–2026) on vitamins/minerals, probiotics/prebiotics, phytochemicals, and deficiency- or dysbiosis-related conditions. Following PRISMA 2020, searches covered PubMed/PMC, Scopus, ScienceDirect, Web of Science, Wiley Online Library, Taylor &amp; Francis Online, MDPI, Frontiers, SAGE, Google Scholar, and WHO/FAO resources. Widespread micronutrient inadequacies were identified, particularly for iron, iodine, calcium, and vitamin E. Intervention evidence was strongest for correcting established deficiencies and selected strain- or outcome-specific probiotic applications. Evidence for extra-skeletal vitamin D effects, broad cardiometabolic prevention, phytochemical supplementation, and microbiome-mediated nutrient benefits was more heterogeneous and often observational or mechanistic rather than definitive clinical trials. Heterogeneity in populations, doses, formulations, comparators, outcomes, and designs precluded quantitative pooling; conclusions were therefore synthesized narratively according to evidence type and risk of bias. Evidence supports food-based dietary adequacy, targeted fortification/supplementation for demonstrated or high-risk deficiency, and cautious use of selected probiotics/prebiotics where strain- and outcome-specific evidence exists. Precision nutrition, biomarker-guided strategies, and microbiome-informed interventions remain insufficiently validated for population-wide implementation. More studies should prioritize adequately powered, long-term, preregistered trials with clinically meaningful outcomes and standardized reporting.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:33:45Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34048468.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Health_benefits_and_physiological_actions_of_micronutrients_probiotics_prebiotics_phytochemicals_and_their_associated_deficiency_diseases_a_systematic_review_of_recent_developments_and_applications/34048468</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
